✦ LIBER ✦

Adalimumab, etanercept, and infliximab utilization patterns and drug costs among rheumatoid arthritis patients

✍ Scribed by Carter, Chureen T.; Changolkar, Arun K.; Scott McKenzie, R.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adalimumab in rheumatoid arthritis after

✍ O. Brocq; C. Albert; C. Roux; D. Gerard; V. Breuil; L. Euller Ziegler 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 48 KB

PMS23 Cost Per Treated Rheumatoid Arthri

✍ M. Bonafede; S.R. Gandra; C. Watson; N. Princic; K.M. Fox 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

PMS31 THE IMPACT OF CHANGES IN ADALIMUMA

✍ RW Lawson; RM Heatley; KI Johnson; RK Khandker; A Singh 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

Treatment persistence with adalimumab, e

✍ Boxiong Tang; Mirza Rahman; Heidi C. Waters; Peter Callegari 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 765 KB

PAR14 COST MINIMIZATION ANALYSIS OF RITU

✍ MG Saggia; EA Santos; V Nasciben 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

Comparison between adalimumab, etanercep

✍ Serene Francis; Md Joel A. Block 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 33 KB 👁 2 views